首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1542909

全球临床实验室服务市场 - 2024-2031

Global Clinical Laboratory Services Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

临床实验室服务市场规模

全球临床实验室服务市场在2023年达到225.6亿美元，预计到2031年将达到4,141.8亿美元，2024-2031年预测期间复合年增长率为6.5%。

临床实验室是医疗产业不可或缺的一部分，其服务在检测、诊断和治疗疾病方面发挥着至关重要的作用。收集样本用于检查和分析体液、组织和细胞。它提供准确的结果，使医生能够做出正确的治疗决定。它还允许医生开始/停止或继续治疗过程，70% 的医疗决策是基于实验室结果。实验室组织正致力于改进其产品，以缩短测试时间并提高效率；因此，它增加了临床实验室的管理。

临床实验室服务市场动态

对这些临床实验室服务的需求不断增长、喉癌发病率上升、研发支出不断增加以及新产品推出的成长预计将推动市场成长。

不断增加的新产品推出和对临床实验室服务的需求将推动市场成长。

全球临床实验室服务市场主要是由医疗保健产业对临床实验室服务的需求所推动的，这是由于慢性疾病的增加和产品发布数量的增加而产生的。正在各个关键领域进行新型诊断分析和临床试验的研究。例如，2022 年 7 月，诊断资讯服务提供者 Quest Diagnostics 宣布推出其最新的分子诊断测试，该测试是实验室开发的，用于帮助诊断猴痘病毒感染。他们计划很快启动疾病预防控制中心的正痘病毒测试。

各种最新的技术正在不断进步，新颖、创新的产品和服务的推出数量也在增加，从而带来了很高的需求。临床实验室的最新创新正在推动市场的成长。例如，2022 年 9 月，Qiagen 宣布在其 NeuMoDx 检测产品组合中新增功能，用于与器官移植相关的病毒。其最新检测方法获得了欧盟和其他多个国家的 CE 体外诊断标誌。这些新颖的检测方法用于识别和定量人类疱疹病毒 6 型和 Epstein-Barr 病毒。

医疗保健提供者面临的高定价压力将阻碍市场的成长。

然而，医疗保健支付者和提供者面临的定价压力以及公众对资料安全和隐私的担忧可能会阻碍市场的进步。

COVID-19 对临床实验室服务市场的影响分析

疫情对全球金融预期、营运和危机应对策略产生了积极影响。 COVID-19 的爆发严重影响了医疗保健产业。临床实验室服务经历了繁荣，其中诊断行业获利最多。由于用于药物研究和诊断目的，因此对检测试剂盒和检测方法的需求量很大。全球各地正在发生各种合作和合併，促进了市场的成长。例如，2022年10月，生命科学公司Labcorp宣布，他们最近与美国非营利医疗系统Ascension完成了交易，这将导致建立长期的实验室关係。

临床实验室服务市场細項分析

预计临床化学领域在预测期内（2024-2031）将以最快的复合年增长率成长

临床化学测试类型细分市场是全球临床实验室服务市场中最大的市场占有者。临床化学涉及分析血液和尿液样本，其中进行与酶学和毒理学相关的各种测试。进行各种定量测试来检查血浆中的一系列物质，例如血糖、荷尔蒙和酵素。由于全球心血管、糖尿病、肝臟、肾臟和血液疾病等目标疾病的发生率增加，临床化学测试在市场上占据主导地位。据世界卫生组织称，2021 年，约有 4.22 亿人患有糖尿病，每年约有 150 万人死亡。每年有 1700 万人死于传染病。创新和先进测试的新颖发展正在促进市场成长。例如，罗氏的 Cobas 8000 模组化分析仪系列是一个血清工作区，是一种基于模组的解决方案，适用于广泛的体外临床化学和免疫化学诊断测试。它是为高通量实验室开发的。

临床实验室服务市场地域份额

北美在全球临床实验室服务市场中占有最大的市场份额。

北美在全球临床实验室服务市场中占据主导地位，这主要归因于公司之间的合作伙伴关係或合作数量不断增加，以及由于医疗保健基础设施完善、可支配收入增加以及研发活动投资增加而导致对临床实验室服务的需求不断增长，这些都促进了北美的测试量的份额增长率。此外，其广泛的患者群体、完善的医疗基础设施、不断增长的可支配收入以及对研发活动的更高投资都有助于北美份额的成长。美国癌症协会估计，2022年美国将新增约190万癌症病例，其中预计将有609,360人死于癌症。

此外，产品发布数量的增加也是市场成长的原因。其他因素，例如国内生产毛额在医疗保健方面的高支出，刺激了市场的成长。许多关键的发展和技术进步都发生在该地区。例如，2022 年 1 月，Exact Sciences 宣布收购预防遗传学，以扩大患者基因癌症检测的可用性。

临床实验室服务公司与竞争格局

临床实验室服务市场与本地和全球公司竞争激烈。 Abbott Laboratories、Bio Reference Laboratories、Exact Sciences Corporation、Myriad Genetics, Inc、Neogenomics Inc、Quest Diagnostics Inc、Siemens Healthineer、Sonic Healthcare Limited、Laboratory Corporation of America、Synlab International GmbH 等。主要参与者正在采取各种成长策略，例如产品发布、併购、合作伙伴关係和协作，为市场的成长做出贡献。例如，2022年10月，诊断资讯服务供应商Quest Diagnostic宣布同意收购Summa Health实验室服务LabCare Plus业务的资产。

雅培实验室

概述：

雅培是一家开发医疗设备和保健产品的跨国公司。它成立于1888年，总部位于美国伊利诺州。他们的产品和服务包括医疗设备、诊断、营养产品和品牌仿製药。

产品组合：

PLEX-ID：它是一种基于分子诊断的技术，整合了质谱和PCR技术，可识别和表征多种微生物。

关键进展：例如，2022 年 5 月，雅培实验室宣布其 Alinity m STI Assay 获得美国 FDA 批准。此测试可检测各种性传染感染，如果不及时治疗，这些感染将成为严重的健康併发症，可能导致不孕和癌症。

全球临床实验室服务市场报告将提供约 40 多个市场资料表、45 多个图表和 200（大约）页。

Clinical laboratories are an integral part of the medical industry, and their services play a crucial role in detecting, diagnosing, and treating disease. Samples are collected to examine and analyze body fluids, tissues, and cells. It provides accurate results that enable physicians to make the right therapeutic decisions. It also allows physicians to start/stop or continue the course of treatment, and 70% of medical decisions are based on laboratory results. Laboratory organizations are focusing on improving their products to shorten the test duration and increase efficiency; thus, it increases the management of clinical laboratories.

Clinical Laboratory Services Market Dynamics

The increasing demand for these Clinical Laboratory Services, the rising incidence of larynx cancer, the increasing research and development expenditure and growth in novel product launches are expected to drive market growth.

The increasing novel product launches and demand for clinical laboratory services will drive market growth.

The global market for clinical laboratory services is primarily driven by the healthcare industry's demand for clinical laboratory services due to increasing chronic disorders and the rising number of product launches. Studies are being conducted on novel diagnostic assays and clinical trials in various key areas. For instance, in Jul 2022, Quest Diagnostics, a diagnostic information service provider, announced its latest molecular diagnostic test that is lab-developed to aid the diagnosis of monkeypox virus infection. They are planning to launch their CDC's orthopoxvirus test soon.

Various latest technological advancements are taking place, and the number of novel, innovative product and service launches is increasing, leading to high demand. The latest innovations by clinical laboratories are driving the growth of the market. For instance, In Sep 2022, Qiagen announced novel additions to their NeuMoDx assay portfolio for the viruses associated with organ transplants. Its latest assays got CE-In Vitro Diagnostic mark for European Union and various other countries. The novel assays are for identifying and quantifying human herpes virus 6 and Epstein-Barr virus.

High pricing pressure faced by healthcare providers will hamper the market's growth.

However, the pricing pressure faced by healthcare payers and providers and public concerns related to data security and privacy may hinder market progress.

COVID-19 Impact Analysis on Clinical Laboratory Services Market

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. Clinical laboratory services have experienced a boom, and the diagnosis sector has profited the most. The demand of test kits and assays are in high demand since they are used for drug research and diagnostic purposes. Various collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Oct 2022, Labcorp, a life-sciences company, announced that they recently completed transactions with Ascension, a non-profit health system in the United States, that would lead to forming a laboratory relationship for a long period.

Clinical Laboratory Services Market Segmentation Analysis

The clinical chemistry segment is expected to grow at the fastest CAGR during the forecast period (2024-2031)

The clinical chemistry test type segment is the highest market holder in the global clinical laboratory services market. Clinical chemistry deals with analyzing blood and urine samples in which various tests related to enzymology and toxicology are performed. Various quantitative tests are performed to examine the range of substances, such as blood sugar, hormones and enzymes in the plasma. The clinical chemistry test dominates the market due to an increase in the occurrence of target diseases such as cardiovascular, diabetes, liver, kidney, and blood disorders globally. According to the WHO, in 2021, around 422 million people had diabetes, and approximately 1.5 million died yearly. Every year 17 million people die due to infectious diseases. The novel development of innovative and advanced tests is increasing market growth. For instance, Roche's Cobas 8000 modular analyzer series is a serum work area that is a module-based solution for a broad range of in vitro clinical chemistry and immunochemistry diagnostic testing. It is developed for high-throughput labs.

Clinical Laboratory Services Market Geographical Share

North America holds the largest market share of the global clinical laboratory services market.

North America dominates the global clinical laboratory services market, primarily attributed to the increasing number of partnerships or collaborations between companies and the rising demand for clinical laboratory services due to established healthcare infrastructure, rising disposable income, and higher investment in R&D activities contribute to North America's share growth% of test volume. Moreover, its broad base patient population and the established healthcare infrastructure and rising disposable income, and higher investment in R&D activities contribute to the growth of North America's share. The American Cancer Society estimated that about 1.9 million new cancer cases would be registered in the U.S. in 2022, of which 609,360 people are expected to die from cancer.

Moreover, the growing number of product launches is responsible for the market's growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market's growth. Many key developments and technological advancements are taking place based in this region. For Instance, in Jan 2022, Exact Sciences announced its acquisition of prevention genetics to expand the availability of genetic cancer testing for patients.

Clinical Laboratory Services Companies and Competitive Landscape

The clinical laboratory services market is highly competitive with local and global companies. Abbott Laboratories, Bio Reference Laboratories, Exact Sciences Corporation, Myriad Genetics, Inc, Neogenomics Inc, Quest Diagnostics Inc, Siemens Healthineer, Sonic Healthcare Limited, Laboratory Corporation of America, Synlab International GmbH and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2022, Quest Diagnostic, a diagnostic information service provider, announced its agreement to acquire assets of Summa Health's business of laboratory services LabCare Plus.

Abbott Laboratories

Overview:

Abbott is a multinational company that develops medical devices and healthcare products. It was founded in 1888 and is headquartered in Illinois, United States. Their products and services include medical devices, diagnostics, nutritional products and branded generic medicines.

Product Portfolio:

PLEX-ID: It is molecular diagnostic-based technology that integrates mass spectrometry and PCR technology and identifies and characterizes a wide range of microorganisms.

Key Development: For instance, in May 2022, Abbott Laboratories announced that its Alinity m STI Assay got cleared by U.S. FDA. This test detects various sexually transmitted infections that, if not treated on time, become serious health complications that can lead to infertility and cancer.

The global clinical laboratory services market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

1. Market Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rising novel product launches
  - 4.1.1.2. Increasing demand for clinical laboratory services
- 4.1.2. Restraints:
  - 4.1.2.1. High pricing pressure faced by the healthcare provider
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces
5.2. Unmet Needs
5.3. Supply chain Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer's Strategic Initiatives
6.6. Conclusion

7. By Test Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 7.1.2. Market Attractiveness Index, By Test Type
7.2. Clinical Chemistry *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Microbiology
7.4. Serology
7.5. Hematology
7.6. Pathology
7.7. Molecular Diagnostics
7.8. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Preclinical & Clinical Trial-Related Services*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Bioanalytical & Lab Chemistry Services
8.4. Drug Discovery & Development Related Services
8.5. Cell & Gene Therapy Related Services
8.6. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospital-based Labs*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Clinic-based Labs
9.4. Stand-alone Labs

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. The U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. The U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch

12. Company Profiles

12.1. Abbott Laboratories
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Key Highlights
- 12.1.4. Financial Overview
12.2. Bio Reference Laboratories
12.3. Exact Sciences Corporation
12.4. Myriad Genetics, Inc
12.5. Neogenomics Inc
12.6. Quest Diagnostics Inc
12.7. Siemens Healthineer
12.8. Sonic Healthcare Limited
12.9. Laboratory Corporation of America
12.10. Synlab International GmbH(*LIST NOT EXHAUSTIVE)

13. DataM Intelligence

13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球临床实验室服务市场 - 2024-2031